# A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma

> **NCT01426113** · PHASE3 · TERMINATED · sponsor: **Allergan** · enrollment: 6 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** bimatoprost ophthalmic solution formulation A
- **DRUG:** timolol ophthalmic solution
- **DRUG:** bimatoprost vehicle

## Key facts

- **NCT ID:** NCT01426113
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Study terminated due to corporate decision.
- **Last updated:** 2015-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426113, "A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01426113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*